CILJF Financial Statements & Analysis
Complete financial statements for CILJF including income statement, balance sheet, and cash flow statement. Analyze CILJF's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
18.1% ↑
Net Income
44.1% ↑
Gross Margin
0.1% ↑
Operating Margin
33.4% ↑
Balance Sheet
Current Ratio
50.9% ↑
Debt to Equity
-36.1% ↑
Asset Turnover
5.4% ↑
Cash Flow
Operating Cash Flow
21.4% ↑
Net Cash Flow
190.9% ↑
Free Cash Flow
21.9% ↑
Cash Flow to Debt
62.6% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 512.20B | 605.11B | 18.1% | |
| Gross Profit | 510.40B | 603.33B | 18.2% | |
| Operating Income | 115.21B | 181.63B | 57.6% | |
| Net Income | 106.94B | 154.08B | 44.1% | |
| EPS | 3.78 | 5.45 | 44.2% | |
| EBITDA | 120.24B | 186.52B | 55.1% | |
| Gross Margin | 99.65% | 99.70% | 0.1% | |
| Operating Margin | 22.49% | 30.02% | 33.4% | |
| Net Income Margin | 20.88% | 25.46% | 22.0% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 605.11B | 512.20B | 396.47B | — | — |
| Gross Profit | 603.33B | 510.40B | 394.74B | — | — |
| Operating Income | 181.63B | 115.21B | 51.99B | — | — |
| Net Income | 154.08B | 106.94B | 51.18B | — | — |
| EPS | 5.45 | 3.78 | 0.75 | — | — |
| EBITDA | 186.52B | 120.24B | 57.00B | — | — |
| Gross Margin | 99.70% | 99.65% | 99.56% | — | — |
| Operating Margin | 30.02% | 22.49% | 13.11% | — | — |
| Net Income Margin | 25.46% | 20.88% | 12.91% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into CILJF's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics